Les anti-inflammatoires et SARS-CoV-2 (COVID-19)

To date, treatment options for severe COVID-19 remain limited and there is currently no effective drug or vaccine for the treatment or prevention of specific SARS-CoV-2 to treat critically ill patients. A new treatment strategy, in addition to antiviral therapy alone, may be required to have a signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Moutaouakkil, Youssef, Tadlaoui, Yasmina, Latt, Esso Eric Valery, Atbib, Yassine, Cherrah, Yahia, Bennana, Ahmed, Bousliman, Yassir, Lamsaouri, Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252016/
http://dx.doi.org/10.1016/j.douler.2020.04.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252016/
http://dx.doi.org/10.1016/j.douler.2020.04.012

Ejemplares similares